INNOVATIVE PHARMACEUTICS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
INNOVATIVE PHARMACEUTICS
Largest movements
- Current investments +€168,988
up €168,988 (+20.1%), from €839,689 to €1.0m
- Cash -€167,131
down €167,131 (-13.6%), from €1.2m to €1.1m
mainly Current investments (-€168,988) and Receivables within one year (-€61,261)
- Receivables within one year +€61,261
up €61,261 (+161%), from €38,070 to €99,331
of which Trade receivables: +€45,251
- Reserves +€77,375
up €77,375 (+3.7%), from €2.1m to €2.2m
- Gross operating margin -€46,536
down €46,536 (-68.7%), from €67,696 to €21,160
- Financial income +€40,620
up €40,620 (+44.4%), from €91,576 to €132,196
- Financial charges +€21,072
up €21,072 (+88.4%), from €23,846 to €44,918
- Provisions -€4,530
down €4,530, from €2,265 to -€2,265
- Taxes -€1,856
down €1,856 (-5.7%), from €32,774 to €30,918
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,164,918 | €2,237,938 | +€73,020 | +3.4% |
| Current assets | 29/58 | €2,164,918 | €2,237,938 | +€73,020 | +3.4% |
| Stocks and contracts in progress | 3 | €62,095 | €71,997 | +€9,902 | +15.9% |
| Stocks | 30/36 | €62,095 | €71,997 | +€9,902 | +15.9% |
| Amounts receivable within one year | 40/41 | €38,070 | €99,331 | +€61,261 | +161% |
| Trade receivables | 40 | €12,396 | €57,647 | +€45,251 | +365% |
| Other amounts receivable | 41 | €25,674 | €41,684 | +€16,010 | +62.4% |
| Current investments | 50/53 | €839,689 | €1,008,677 | +€168,988 | +20.1% |
| Cash at bank and in hand | 54/58 | €1,225,064 | €1,057,933 | -€167,131 | -13.6% |
| Total equity and liabilities | 10/49 | €2,164,918 | €2,237,938 | +€73,020 | +3.4% |
| Equity | 10/15 | €2,146,896 | €2,224,271 | +€77,375 | +3.6% |
| Contributions | 10/11 | €30,000 | €30,000 | = | 0.0% |
| Reserves | 13 | €2,116,896 | €2,194,271 | +€77,375 | +3.7% |
| Distributable reserves | 133 | €2,116,896 | €2,194,271 | +€77,375 | +3.7% |
| Provisions and deferred taxes | 16 | €2,265 | - | -€2,265 | |
| Provisions for liabilities and charges | 160/5 | €2,265 | - | -€2,265 | |
| Other liabilities and charges | 164/5 | €2,265 | - | -€2,265 | |
| Amounts payable | 17/49 | €15,757 | €13,667 | -€2,090 | -13.3% |
| Amounts payable within one year | 42/48 | €15,757 | €13,667 | -€2,090 | -13.3% |
| Trade debts | 44 | €2,179 | €5,929 | +€3,750 | +172% |
| Suppliers | 440/4 | €2,179 | €5,929 | +€3,750 | +172% |
| Taxes, remuneration and social security | 45 | €13,578 | €7,738 | -€5,840 | -43.0% |
| Taxes | 450/3 | €13,578 | €7,738 | -€5,840 | -43.0% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €2,265 | -€2,265 | -€4,530 | |
| Other operating charges | 640/8 | €1,828 | €2,410 | +€582 | +31.8% |
| Gross operating margin | 9900 | €67,696 | €21,160 | -€46,536 | -68.7% |
| Operating profit (loss) | 9901 | €63,603 | €21,015 | -€42,588 | -67.0% |
| Financial income | 75/76B | €91,576 | €132,196 | +€40,620 | +44.4% |
| Recurring financial income | 75 | €91,576 | €132,196 | +€40,620 | +44.4% |
| Financial charges | 65/66B | €23,846 | €44,918 | +€21,072 | +88.4% |
| Recurring financial charges | 65 | €23,846 | €44,918 | +€21,072 | +88.4% |
| Profit (loss) for the period before taxes | 9903 | €131,333 | €108,293 | -€23,040 | -17.5% |
| Income taxes | 67/77 | €32,774 | €30,918 | -€1,856 | -5.7% |
| Profit (loss) for the period | 9904 | €98,559 | €77,375 | -€21,184 | -21.5% |
| Profit (loss) for the period to be appropriated | 9905 | €98,559 | €77,375 | -€21,184 | -21.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.